Fig. 2From: Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemicPrior distributions of ARDLT for the 4 doses, based on the calibrated prior parameters. The vertical dotted lines represent the desirable range of additional toxicity (15–25%). The percentages in the header of each graph represent the probability that the ARDLT for the dose lies within this intervalBack to article page